Selected Publications
Bakas S, Sako C, Akbari H, Bilello M, Sotiras A, Shukla G, Rudie JD, Santamaría NF, Kazerooni AF, Pati S, Rathore S, Mamourian E, Ha SM, Parker W, Doshi J, Baid U, Bergman M, Binder ZA, Verma R, Lustig RA, Desai AS, Bagley SJ, Mourelatos Z, Morrissette J, Watt CD, Brem S, Wolf RL, Melhem ER, Nasrallah MP, Mohan S, O'Rourke DM, Davatzikos C: The University of Pennsylvania glioblastoma (UPenn-GBM) cohort: advanced MRI, clinical, genomics, & radiomics Sci Data 9 (1): 2022.
Nelson N, Priore S, Sondermann J, Herlihy S, Watt CD: Evaluation of Positive Control Material for MGMT Promoter
Methylation Studies Journal of Molecular Diagnostics 23 (11): 1618,2021.
Gentile C, Richard-Greenblatt M, Fink J, Elkan M, Harris RM, Van Deerlin VM, Glaser L, Watt CD, Herlihy SE: A Practical Comparison of Seven Molecular SARS-CoV-2 Methods The Journal of Molecular Diagnostics 22 (11): S33,2020.
Zhang Q, Orlando EJ, Wang HY, Bogusz AM, Liu X, Lacey SF, Strauser HT, Nunez-Cruz S, Nejati R, Zhang P, Brooks S, Watt CD, Melenhorst JJ, June CH, Schuster SJ, Wasik MA: Transdifferentiation of lymphoma into sarcoma associated with profound reprogramming of the epigenome Blood 136 (17): 1980-1983,2020.
Herlihy SE, Carlin A, Nasrallah NP, Watt CD and Van Deerlin VM: Evaluation of a Targeted Realtime Assay for Rapid Identification of IDH1 and IDH2 Disease-Associated Variants in Brain Tumors The Journal of Molecular Diagnostics 21 (6): 1201,2019.
Garces S, Nelson N, Watt CD, and Priore S: FLT3 Variants Near Codon 835: An Institutional Experience Comparing Rapid Restriction Digest Testing with Massively Parallel Sequencing. The Journal of Molecular Diagnostics 21 (6): 1230,2019.
McMahon C, Ferng T, Canaani J, Wang E, Morrissette J, Eastburn D, Pellegrino M, Durruthy-Durruthy R, Watt CD, Asthana S, Lasater E, DeFilippis RA, Peretz C, McGary L, Deihimi S, Logan A, Luger S, Shah N, Carroll M, Smith C, and Perl A: Clonal selection with Ras pathway activation mediates secondary clinical resistance to selective FLT3 inhibition in acute myeloid leukemia. Cancer Discovery 9 (8): 1050-1063,2019.
Brown JT, Beldorth IJ, Laosinchai-Wolf W, Fahey ME, Jefferson KL, Ruskin AK, Roth JJ, Cai L, Watt CD, Press RD, Yang F, Hedges JB, and Andruss BF: Analytical validation of a highly sensitive, multiplexed chronic myeloid leukemia monitoring system targeting BCR-ABL1 RNA. The Journal of Molecular Diagnostics 21 (4): 718-733,2019.
Nasrallah MP, Binder ZA, Oldridge DA, Zhao J, Lieberman DB, Roth JJ, Watt CD, Sukhadia S, Klinman E, Daber RD, Desai A, O’Rourke DM, and Morrissette JJD: Molecular neuropathology in practice: Clinical profiling and integrative analysis of molecular alterations in glioblastoma. Academic Pathology 6 : 2374289519848353,2019.
McMahon CM, Canaani J, Rea B, Sargent R, Watt CD, Morrissette JJD, Carroll M, and Perl AE: Gilteritinib induces differentiation in relapsed and refractory FLT3-mutated acute myeloid leukemia. Blood Advances 3 (10): 1581-1585,2019.
Academic Contact Information
Department of Pathology and Laboratory Medicine
Hospital of the University of Pennsylvania
3400 Spruce Street
Philadelphia,
PA
19104